Latest stories on NBIX
Neurocrine Biosciences Q2 2026 Earnings Preview
Seeking Alpha56 · neutralearnings
Neurocrine Biosciences Announces Key Leadership Hiring, Promotions
PR Newswire63 · neutralgeneral
Neurocrine Biosciences Announces Key Leadership Hiring, Promotions | NBIX Stock News
StockTitan56 · neutralgeneral
Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer
PR Newswire56 · neutralgeneral
Stock Market Today: Monday Gap Up Doesn’t Hold; Neurocrine Bio, Rush Street, Burlington In Focus
Investors.com50 · neutralgeneral
Neurocrine Shares Hit Highs on Sales Spike, Strong Pipeline
Yahoo Finance73 · bullishproduct/pr
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results
PR Newswire50 · neutralgeneral
Tardive Dyskinesia Market to Grow Rapidly at a CAGR of 8.1% During the Forecast Period (2026-2036) | DelveInsight
PR Newswire63 · neutralgeneral
Chart of the Day: A Breakout Could Be Brewing in Neurocrine Biosciences
Barron's63 · neutralgeneral
Is Neurocrine Biosciences, Inc. (NBIX) A Good Stock To Buy Now?
Yahoo Finance57 · neutralanalyst
Neurocrine Biosciences, Inc. (NBIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
RBC Capital Raises its Price Target on Neurocrine Biosciences (NBIX)
Yahoo Finance61 · neutralanalyst
Neurocrine Biosciences, Inc. (NBIX) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Seeking Alpha55 · neutralgeneral
Neurocrine Shareholders Reelect Directors and Approve Governance Measures
TipRanks50 · neutralgeneral
Neurocrine Biosciences: Quantitative Stock of the Week
Barron's73 · bullishanalyst